Srphc82281246-Coronary Drug Eluting Stents With (1) Cobalt Chromium Allo Y And With Coating Of Polymer Carrier For Active Drug Everolimus. (2) Crossing Profile L Ess Than Or Equal To 0.0425 Inch And Mid Marker Stent Placement. (3) Stent Diameter Sho Uld Be From 2.0 Mm To 4 Mm And Length Of The Stent From 8 Mm To 38 Mm. (4) The Strut Thi Ckness Should Be 81 Micron. (5) Stent Delivery System Should Be Monorail (Single Operat Or Exchange Or Rapid Exchange). (6) Stent Should Be Compatible With 5Fr Guiding Catheter (7) Stent Design Should Be Open Cell Type. (8) Stent Should Be Approved By Dcgi. The Copy Of Dcgi Approval Should Be Enclosed In The Tender Bid. (9) The Long Term Effica Cy And Safety Of The Stent In Terms Of Target Vessel Revascularisation (Tvr) And In-Situ Thrombosis (Ist) Should Be Documented / Published In Peer Reviewed Scientific Journals.( 10) The Documents Pertaining To The Efficacy And Safety Of The Stent Should Be Enclose D In The Tender Bid (11) The Manufacturer/Supplier Should Submit Proof Of Supply Of The Stent To A Major Government Institute. [Quantity Tolerance (+/-): 5 %Age , Item Category : Normal , Total Po Value Variation Permitt Ed: Max 8 Lacs ] ]